Year: 2025
ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 2,250,000 shares of common stock (or pre-funded warrant in lieu thereof) and Series F warrants to purchase up to 4,500,000 shares of common stock at a purchase price of $2.00 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying warrants in a private placement priced at-the-market under Nasdaq rules. The Series F warrants will have an exercise price of $1.75 per share and will be exercisable immediately upon issuance. The Series F warrants will expire 5.5 years from the date of issuance. The...
CORRECTION: Premier Reports Strong Quarterly Results, Demonstrating Continued Growth in Hawaii and Mexico Markets
Written by Customer Service on . Posted in Public Companies.
CARLSBAD, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) — In a release issued under the same headline on October 9th, by Premier Air Charter Holdings, Inc. (OTC ID: PREM), please note that the charter sales revenue and year-to-date charter revenue figures incorrectly listed 2024 instead of 2025. The corrected release follows:
Premier Air Charter Holdings, Inc. (OTC ID: PREM) (“Premier Air Charter”, “Premier” or the “Company”), is pleased to announce another strong quarter, reflecting the company’s sustained momentum and strategic expansion across key markets. The latest results underscore Premier’s growing presence in both Hawaii and Mexico, driven by increased demand and effective execution of the Company’s regional growth initiatives.
Premier Delivers Strong Charter Sales Growth Across Key Markets
Premier Air Charter is proud to report...
Festi hf.: Publication of Base Prospectus
Written by Customer Service on . Posted in Public Companies.
Festi hf., kt. 540206-2010, Dalvegur 10-14, 201 Kópavogur, has published a base prospectus in connection with issuance programme for bonds and bills. The base prospectus, dated 9 October 2025, has been approved by the Financial Supervisory Authority of the Central Bank of Iceland. The prospectus is issued in Icelandic and published electronically on Festi’s website, https://www.festi.is/en/skuldabrefogvixlar.
The Prospectus will be available on Festi’s website for ten years from the date of its approval.
Íslandsbanki hf. managed the process of having the prospectus approved by the Financial Supervisory Authority of the Central Bank of Iceland.
For further information, please contact Magnús Kr. Ingason, CFO of Festi hf. (mki@festi.is).AttachmentGrunnlýsing Festi 2025
ASUS ExpertBook P3 Empowers Agile Businesses with AI-Powered Performance and Enterprise-Grade Security
Written by Customer Service on . Posted in Public Companies.
All-around Copilot+ PC for SMBs powered by AMD Ryzen™ AI Processors
KEY POINTSFastest AI performance: ExpertBook P3 delivers up to 66 total system TOPS of AI power with up to AMD Ryzen™ AI 7 processors for sustained productivity
Comprehensive AI Productivity: Preloaded with ASUS ExpertMeet, an AI-powered conferencing tool that elevates meeting experiences
Business-grade security: Protected by ASUS ExpertGuardian from software to hardware, including a NIST SP 800-155 compliant BIOS, Windows 11 Secured-core technologiesTORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) — ASUS today announced the brand-new ExpertBook P3 Series is now available in Canada in 14-inch (PM3406) and 16-inch (PM3606) variants. It is a Copilot+ PC designed to deliver business-level performance in a portable, secure package for today’s agile...
ASUS Brings AI-Powered ExpertCenter P700 Business Desktops to Canada
Written by Customer Service on . Posted in Public Companies.
AI-powered business desktops combine next-generation performance, whisper-quiet cooling, intelligent collaboration tools, and business-grade security
KEY POINTSPowerful performance: Up to AMD Ryzen™ AI 7 350 processor with 50 NPU TOPS, NVIDIA® RTX™ A400 graphics, and up to 64GB DDR5 memory
Quiet and reliable: Advanced cooling with copper heat pipe and high-efficiency fan sustains 45W TDP while staying whisper-quiet
AI-ready for business: Copilot+ PC features plus ASUS AI ExpertMeet with smart meeting transcription, real-time translation and more
Secure and durable: ASUS ExpertGuardian with TPM 2.0, BIOS Self-Recovery, and military-grade durability backed by ASUS supportTORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) — ASUS today announced ExpertCenter P700 series, an all-new lineup of business desktops designed to deliver...
ASUS Brings AI-Powered ExpertCenter P600 AiO Business PC to Canada
Written by Customer Service on . Posted in Public Companies.
Next-generation AI performance meets immersive design and enterprise-grade security for smarter, faster business
KEY POINTSClass-leading AI performance: First ASUS AiO Copilot+ PC, with up to AMD Ryzen™ AI 7 with 50 NPU TOPS, 64GB DDR5 memory and 2TB SSD
Everyday business intelligence: ASUS AI ExpertMeet with transcription, translation, noise cancelation and AI camera
Immersive design: 24″ FHD display with 93% screen-to-body ratio, TÜV certification, retractable camera and height-adjustable stand
Secure and sustainable: ExpertGuardian security, MIL-STD 810H durability, Digital Product Passport and ASUS Carbon Partner ServicesTORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) — ASUS today announced ExpertCenter P600 AiO, the first ASUS all-in-one Copilot+ PC, designed to deliver next-generation AI performance for business....
Hammond Power Solutions Announces Third Quarter 2025 Financial Results Conference Call and Webcast Notification
Written by Customer Service on . Posted in Public Companies.
GUELPH, Ontario, Oct. 09, 2025 (GLOBE NEWSWIRE) — Hammond Power Solutions Inc. (“HPS” or the “Company”) (TSX: HPS.A) today announced that it will release its financial results for the Third Quarter ended September 27, 2025, on Thursday, October 23, 2025, after markets close. Following the release of its financial results, HPS will hold a conference call and webcast on Friday, October 24, 2025, at 9:00 a.m. Eastern Time.
This call can be accessed by registration through participant links:
Date/Time: October 24, 2025/ 9 a.m. ET
Live Call Participant Registration Link:
https://register-conf.media-server.com/register/BI593d1bc2a3a34716bd6de7eee47824de
Audio-Only Webcast:
https://edge.media-server.com/mmc/p/ubgd2pp6
A webcast replay will be available for 12 months.
ABOUT HAMMOND POWER SOLUTIONS INC.Hammond Power Solutions Inc. (“HPS”...
Final Collection of Luxury Townhomes Opens in Rivington by Toll Brothers 55+ Active-Adult Community in Danbury, Connecticut
Written by Customer Service on . Posted in Public Companies.
DANBURY, Conn., Oct. 09, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the opening of the final collection of luxury townhomes in its Rivington by Toll Brothers 55+ active-adult community in Danbury, Connecticut. The Meadows Collection within this vibrant community in Fairfield County will offer 64 townhomes in a beautiful natural setting with access to resort-style amenities. The Sales Center is now open at 5 Reserve Road in Danbury.
Located just along the New York-Connecticut border, Rivington by Toll Brothers – The Meadows Collection provides home buyers a final opportunity to purchase a new luxury townhome in the amenity-rich Rivington master plan. Modern home designs will feature first-floor primary bedroom suites, up to four bedrooms, offices, open-concept...
Karolinska Development’s portfolio company PharmNovo receives approval to initiate a phase 2a trial of its drug candidate PN6047 in Spain
Written by Customer Service on . Posted in Public Companies.
STOCKHOLM, SWEDEN – October 9, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company PharmNovo has received approval from the Spanish regulatory authorities to initiate a phase 2a clinical trial of its drug candidate, PN6047, being developed as a treatment for neuropathic pain. The trial will be conducted in the EU, but has been fully aligned with the requirements defined by the U.S. Food and Drug Administration (FDA), earlier this year.
The Spanish Health Authorities have approved PharmNovo’s clinical trial application (CTA) to conduct a phase 2a clinical trial investigating the safety and efficacy of the lead candidate, PN6047, in patients with neuropathic pain. The trial will be initiated in Spain, but PharmNovo plans to also submit applications to expand the study to Czech Republic and...
Soul Street Ventures Announces First Portfolio Exit with Acquisition of Sirvatus by Carta
Written by Customer Service on . Posted in Mergers And Acquisitions.
Milestone Deal Underscores Soul Street’s Mission to Back Purpose-Driven Founders and Deliver Meaningful Outcomes for its Portfolio
HOUSTON and ST. LOUIS, Oct. 09, 2025 (GLOBE NEWSWIRE) — Soul Street Ventures, which prioritizes founders over spreadsheets, today announced its first portfolio exit with the acquisition of Sirvatus by Carta, the leading equity management platform for startups, investors, and employees. The deal marks a significant milestone for Soul Street Ventures, reaffirming its dedication to helping early-stage founders grow impactful businesses. Financial terms were not disclosed.
Founded in 2020, Sirvatus is a modern loan operations platform designed specifically for private credit. Focused on managing complex deal structures, Sirvatus offers a comprehensive end-to-end solution for controlling private credit operations....